Drug application
PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE)
Drugs@FDA ANDA 040660 · PAI HOLDINGS
Key facts
| Drug name | PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE |
|---|---|
| Active ingredients | CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 040660 |
| Company | PAI HOLDINGS |
| Dosage forms | SYRUP, ORAL |
| Strength | 10MG/5ML;5MG/5ML;6.25MG/5ML |
| Marketing status | Prescription |
| TE codes | AA |
| Reference listed drug | No |
| Latest submission status date | Dec 7, 2006 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- No FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: